**Core Concept**
In bronchial asthma, chronic inflammation and airway hyperresponsiveness are key features. The level of certain compounds in the airways is altered due to this inflammation. One such compound plays a crucial role in modulating the inflammatory response and airway tone.

**Why the Correct Answer is Right**
The correct answer is leukotriene E4 (LTE4). Leukotrienes are a group of eicosanoids produced from arachidonic acid by the action of 5-lipoxygenase enzyme. They are potent bronchoconstrictors and are involved in the pathogenesis of asthma. LTE4 is a stable metabolite of leukotriene C4 and is a good marker of leukotriene production. Its levels are elevated in the urine of patients with asthma, especially those with severe disease.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is not relevant to the question. Although histamine is involved in the pathogenesis of asthma, its level is not a good marker of disease severity.
* **Option B:** This option is incorrect because prostaglandin D2 (PGD2) is involved in the pathogenesis of asthma, but its level is not a good marker of disease severity.
* **Option C:** This option is incorrect because thromboxane A2 (TXA2) is involved in platelet aggregation and vasoconstriction, but its level is not elevated in asthma.

**Clinical Pearl / High-Yield Fact**
Leukotriene modifiers are a class of medications that prevent the production of leukotrienes and are used in the treatment of asthma. These medications can be used as add-on therapy to inhaled corticosteroids in patients with severe asthma.

**Correct Answer:** C. Leukotriene E4 (LTE4).